GORMAN KEVIN CHARLES - Insider Non-Derivative Transactions at NEUROCRINE BIOSCIENCES INC (NBIX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 13, 2024, GORMAN KEVIN CHARLES's relationship to NEUROCRINE BIOSCIENCES INC (NBIX) is Director,Officer (Chief Executive Officer), and currently has 514,596 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NBIX insiders.

Data Source: SEC.
GORMAN KEVIN CHARLES - Insider Non-Derivative Transactions of NBIX Common Stock
GORMAN KEVIN CHARLES - Insider Non-Derivative Transactions at NBIX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 14, 2024 M -- (Common Stock) 2778 35.99 509740
Feb 14, 2024 M -- (Common Stock) 2312 43.24 512052
Feb 14, 2024 Sell -- (Common Stock) 2832 133.02 514596
Feb 9, 2024 Sell -- (Common Stock) 2274 134.15 506962
Feb 7, 2024 Sell -- (Common Stock) 3040 142.18 504919
Feb 1, 2024 Sell -- (Common Stock) 2707 140.69 502188
Jan 10, 2024 Sell -- (Common Stock) 62023 134.01 499754
Jan 10, 2024 M -- (Common Stock) 62023 19.59 561777
Jan 9, 2024 Sell -- (Common Stock) 105835 132.44 499754
Jan 9, 2024 M -- (Common Stock) 105835 19.59 605589
Aug 22, 2023 Sell -- (Common Stock) 9328 107.4 499754
Feb 9, 2023 Sell -- (Common Stock) 2274 104.3 491365
Feb 8, 2023 Sell -- (Common Stock) 3248 102.3 470930
Feb 8, 2023 Sell -- (Common Stock) 20482 102.43 489322
Feb 7, 2023 Sell -- (Common Stock) 3040 105.68 468008
Feb 1, 2023 Sell -- (Common Stock) 2707 110.08 465278